Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Loxo Oncology CS (LOXO)

81.87 +4.17 (+5.37%)

6/28/2017  4:00pm

Open:

79.80

Pre. Close:

77.70

High:

82.16

Low:

78.10

Volume:

566,747

Market Cap:

2.14B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

82.46 - 84.82

84.82 - 86.01

Low:

73.63 - 75.97

75.97 - 77.13

Close:

78.39 - 82.24

82.24 - 84.17

Technical analysis  (as of: 2017-06-28 4:38:01 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 97.08     One year: 113.39

Support:

Support1: 58.96    Support2: 44.02

Resistance:

Resistance1: 83.12    Resistance2: 97.08

Pivot:

75.46

Moving Averages:

MA(5): 80.04     MA(20): 69.47

MA(100): 49.42     MA(250): 36.27

MACD:

MACD(12,26): 7.92     Signal(12,26,9): 7.50

%K %D:

%K(14,3): 85.07     %D(3): 87.52

RSI:

RSI(14): 72.11

52-Week:

High: 82.16  Low: 17.14  Change(%): 257.8

Average Vol(K):

3-Month: 439  10-Days 876

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
LOXO has closed below upper band by 8.1%. Bollinger Bands are 32.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 05 Jun 2017 17:36:44 GMT
Here's Why Loxo Oncology Soared as Much as 58.5% Today

Tue, 13 Jun 2017 20:26:15 GMT
Loxo Oncology launching secondary offering to fund drug research

Mon, 05 Jun 2017 11:48:45 GMT
Loxo Oncology jumps 34% premarket on news of positive cancer drug trial

Tue, 13 Jun 2017 13:29:14 GMT
Excitement from ASCO: TG Therapeutics, Loxo Oncology, and Bluebird Bio

Tue, 30 May 2017 10:46:26 GMT
Loxo Oncology Announces FDA Clearance of Investigational New Drug (IND ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

26.15

Shares Float (M)

16.84

% Held by Insiders

17.09

% Held by Institutions

87.90

Shares Short (K)

3620

Shares Short Prior Month (K)

3880

Stock Financials

EPS

-3.800

EPS Est. Current Year

-4.220

EPS Est. Next Year

-4.440

EPS Est. Next Quarter

-1.040

Forward EPS

-4.441

Book Value (p.s.)

9.140

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-27.2

Return on Equity (ttm)

-44.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-3.300

Qtrly Earnings Growth

Operating Cash Flow (M)

-68.48

Levered Free Cash Flow (M)

-37.58

FoxReading.com

Valuation

P/E

-21.54

P/E Growth Ratio

0.05

P/BV

8.96

P/S

P/CF

-31.26

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.